Eisenmenger’s syndrome epidemiology and demographics

Jump to navigation Jump to search

Eisenmenger’s syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eisenmenger’s syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Reproduction

Eisenmenger’s syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eisenmenger’s syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eisenmenger’s syndrome epidemiology and demographics

CDC on Eisenmenger’s syndrome epidemiology and demographics

Eisenmenger’s syndrome epidemiology and demographics in the news

Blogs on Eisenmenger’s syndrome epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Eisenmenger’s syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview


Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

Prevalence

  • Overall, about 8% of patients with congenital heart disease develop Eisenmenger's syndrome.[1]
  • About 3% of patients with a small VSD (≤1.5 cm) and 50% of patients with a large VSD (>1.5 cm) develop Eisenmenger's syndrome.[2]
  • However, the prevalence is currently decreasing due to improved detection methods of congenital heart defects.

Case-fatality rate/Mortality rate

  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Eisenmenger's syndrome usually manifests before puberty.
  • But it may also manifest during adolescence and early adulthood.[3]

Race

  • There is no racial predilection to Eisenmenger's syndrome.

Gender

  • Eisenmenger's syndrome affects men and women equally.

Developed Countries

The prevalence of Eisenmenger's syndrome is less common in developed countries due to better healthcare access.

Developing Countries

The prevalence of Eisenmenger's syndrome is more common in developing countries due to poor healthcare access.

References

  1. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G; et al. (1998). "Eisenmenger syndrome. Factors relating to deterioration and death". Eur Heart J. 19 (12): 1845–55. doi:10.1053/euhj.1998.1046. PMID 9886728.
  2. Kidd L, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, O'Fallon WM; et al. (1993). "Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects". Circulation. 87 (2 Suppl): I38–51. PMID 8425321.
  3. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G; et al. (1998). "Eisenmenger syndrome. Factors relating to deterioration and death". Eur Heart J. 19 (12): 1845–55. doi:10.1053/euhj.1998.1046. PMID 9886728.

Template:WH Template:WS